Your browser doesn't support javascript.
loading
Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes
Yonsei Medical Journal ; : 534-540, 1998.
Artigo em Inglês | WPRIM | ID: wpr-207246
ABSTRACT
We analyzed the fluoroquinolone resistance mechanism of 28 isolates of ciprofloxacin-resistant E. coli from patients who received ciprofloxacin as a regimen of a selective gut decontamination. Isolates distinctive by infrequent restriction site polymerase chain reaction (IRS-PCR) were subjected to Hinf I restriction fragment length polymorphism analysis, single-stranded conformation polymorphism (SSCP), and nucleotide sequencing of the quinolone resistance determining region (QRDR) in gyrA. Double mutations in QRDR of gyrA (Ser83 Leu and Asp87Asn) were found from most of the strains. Nucleotide sequencing of the marR locus showed that 18 out of 28 (64%) ciprofloxacin-resistant E. coli strains had three types of base change in marR loci a double-base change at nucleotides 1628 and 1751, or 1629 and 1751 and a single-base change at 1751. However, all the mutated strains showed no tolerance to cyclohexane test, suggesting the mutation in the marR region had no influence on overexpression of the MarA protein. In conclusion, mutation in gyrA was the main mechanism of ciporfloxacin resistance in E. coli from patients with selective gut decontamination. Therefore, mutation in the mar region did not influence the levels of ciprofloxacin resistance in our isolates.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Resistência Microbiana a Medicamentos / Ciprofloxacina / DNA Topoisomerases Tipo II / Resistência a Múltiplos Medicamentos / Escherichia coli / Mutação Limite: Humanos Idioma: Inglês Revista: Yonsei Medical Journal Ano de publicação: 1998 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Resistência Microbiana a Medicamentos / Ciprofloxacina / DNA Topoisomerases Tipo II / Resistência a Múltiplos Medicamentos / Escherichia coli / Mutação Limite: Humanos Idioma: Inglês Revista: Yonsei Medical Journal Ano de publicação: 1998 Tipo de documento: Artigo